Clinical Studies

Enrolling:

INDICATIONPRE-QUALIFYING CRITERIABASIC STUDY INFORMATION
NON-ALCOHOLIC STEATOHEPATITIS (NASH)*18+ YEARS OLD
*CONFIRMED NASH DIAGNOSIS
THIS CLINICAL STUDY IS FOR INDIVIDUALS WITH CONFIRMED NASH DIAGNOSIS. STUDY DURATION IS 27 MONTHS.
ECZEMA (ATOPIC DERMATITIS)*12 – 75 YEARS OF AGE
*MODERATE – SEVERE ECZEMA
A CLINICAL STUDY FOR INDIVIDUALS WHO CURRENTLY HAVE MODERATE TO SEVERE ECZEMA. STUDY DURATION IS 140 WEEKS.
HUMAN IMMUNODEFICIENCY VIRUS (HIV)*18+ YEARS OF AGE
*HIV +
A CLINICAL STUDY FOR INDIVIDUALS WITH CCR5-TROPIC HIV-1 AND ARE VIROLOGICALLY SUPPRESSED. STUDY DURATION IS 58 WEEKS.
HUMAN IMMUNODEFICIENCY VIRUS (HIV)*18+ YEARS OF AGE
*HIV +
A CLINICAL STUDY FOR INDIVIDUALS WHO ARE HIV+ AND ARE VIROLOGICALLY SUPPRESSED. THREE PART STUDY: PART 1 & 2 STUDY DURATION IS UP TO 24 WEEKS; PART 3 STUDY DURATION IS UP TO 36 WEEKS.
DIABETES MELLITUS TYPE 1
*18 – 65 YEARS OF AGE
*DIABETES MELLITUS TYPE 1
*ON A STABLE DOSE OF ONCE DAILY BASAL LANTUS OR TUOJEO INJECTION
AND
*MULTIPLE DAILY BOLUS NOVOLOG OR HUMALONG INJECTIONS FOR AT LEAST 3 MONTHS
A CLINICAL STUDY FOR INDIVIDUALS WITH TYPE 1 DIABETES MELLITUS. STUDY DURATION IS 35 WEEKS.
LUNG CANCER*35+ YEARS OF AGE
*CT SCAN CONFIRMED NODULE(S) WITHIN 90 DAYS
BLOOD SAMPLE COLLECTION STUDY FOR INDIVIDUALS WITH SUSPICION OR A DIAGNOSIS OF LUNG CANCER
LUNG CANCER*50+ YEARS OF AGE
*A CANDIDATE FOR LDCT LUNG CANCER SCREENING AND SCHEDULED FOR A LDCT SCAN
OR
*HAVE HAD A PREVIOUS LDCT SCAN(S) FOR LUNG CANCER SCREEINING AND MOST RECENT LDCT SCAN IS NEGATIVE FOR PULMONARY NODULES
BLOOD SAMPLE COLLECTION STUDY FOR INDIVIDUALS WHO ARE CURRENTLY IN A LUNG CANCER SCREENING PROGRAM

Upcoming:

*MALIGNANT MELANOMA (MM) BLOOD SAMPLE CLINICAL STUDY*BRONCHIECTASIS (NON-CYSTIC FIBROSIS) CLINICAL STUDY
*IDIOPATHIC PULMONARY FIBROSIS CLINICAL STUDY*ULCERATIVE COLITIS (UC) CLINICAL STUDY

Clinical Trial Experience:

  • Infectious Diseases
    • Clostridium difficile (C. diff)
    • Gonorrhea
    • Human Immunodeficiency Virus (HIV)
  • Pulmonology
    • Bronhiectasis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Pulmonary Arterial Hypertension (PAH)
  • General Medicine
    • Diabetes Mellitus Type II
    • Dyslipidemia
    • Hypertension
  • Gastrointestinal
    • Chronic Constipation
  • General Surgery
    • Wound Care
  • Dermatology
    • Acne Vulgaris
    • Actinic Keratosis (pre-cancerous lesions)
    • Alopecia Areata (hair-loss)
    • Atopic Dermatitis (eczema)
    • Plaque Psoriasis